This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay D is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
Disclaimer
The content on this website should not be construed as providing medical advice/guidance. BrainsWay manufactures and is a holder of rights in the technology behind the BrainsWay products, but is NOT licensed to provide treatments or to advise patients directly regarding treatment options. For questions related to your medical care, or in the case of emergency, please contact your doctor or local emergency services provider.